Chiba, Japan

Koji Kusano


Average Co-Inventor Count = 8.9

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Narita, JP (2000)
  • Chiba, JP (2004)

Company Filing History:


Years Active: 2000-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Koji Kusano: Innovator in Pharmaceutical Chemistry

Introduction

Koji Kusano is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on imidazole and pyridine derivatives. His research has led to the development of compounds that exhibit promising therapeutic activities.

Latest Patents

Kusano holds 2 patents that focus on novel pharmaceutical compounds. His latest patents include imidazole derivatives or their salts, which are designed to exhibit G-CSF-like activities. These compounds can serve as substitutes for G-CSF preparations, providing potential benefits in medical treatments. Additionally, he has developed a pyridine derivative and a medicament containing the same, which further showcases his expertise in creating effective pharmaceutical solutions.

Career Highlights

Throughout his career, Koji Kusano has worked with reputable companies such as Ssp Co. Ltd and Ss Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to various innovative projects in the pharmaceutical industry.

Collaborations

Kusano has collaborated with esteemed colleagues, including Koichi Tachibana and Susumu Sato. These partnerships have facilitated the exchange of ideas and fostered advancements in their shared field of research.

Conclusion

Koji Kusano's work in pharmaceutical chemistry exemplifies the impact of innovation on healthcare. His patents and collaborations highlight his commitment to developing effective medical solutions. His contributions continue to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…